🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 23283B204
- Market Cap
- Micro Cap · $48 Million
- Previous Symbol
- GTF (changed 4/10/2000)
- Previous Name
- AutoLogous Wound Therapy, Inc.
Business: Cytomedix, Inc. is an autologous regenerative therapies company. Their synergistic blood and bone marrow fractionation techniques are intended to provide patients and clinicians with innovative treatment options by harnessing the regenerative capacity of a patient’s own cells. Commercially, they market advanced platelet rich plasma systems in the US and Internationally. Their regenerative cell therapies pipeline using proprietary ALDH bright cell ("ALDHbr") technology, is based on a marker of biologic activity to identify pluri-potential progenitor cells. Currently, a Phase 2 trial for the treatment of ischemic stroke using ALDHbr Bright Cells is underway.
Company Contact
- CEO
- Martin P. Rosendale
- CFO
- Andrew S. Maslan
- Headquarters
- 209 Perry Parkway, Suite 7, Gaithersburg, MD 20877
- Phone
- 240-499-2680
- Fax
- 240-499-2690
- Investor Relations
- 240-499-2680 · customercare@cytomedix.com